Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-26

Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of HR18042 Tablets for Postoperative Analgesia After Impacted Teeth Removal Surgery. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating HR18042 tablets for postoperative analgesia after impacted teeth removal has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HR18042 Tablets

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Pain | Phase 2 | Status: TERMINATED